




































Many pharma companies and CROs are partnering with digital health companies as a way to improve patient enrollment, collect patient data remotely and optimize the design of the trial. What should pharma and CROs look for when partnering with innovative clinical trials solutions, companies specialized in specific stages (i.e patient recruitment, data collection & analysis, site selection, etc) or end to end products? Where is the greatest, and quickest opportunity to show impact? As benefits for pharma and CROs are probably longer term, how important is it to focus on culture and change in mindset to make these partnerships thrive? Join this meeting to discuss this and more with thought leaders in the field.